Skip to main content
Premium Trial:

Request an Annual Quote

Booster Support

An advisory committee to the US Centers for Disease Control and Prevention has indicated its support for booster doses of SARS-CoV-2 vaccines, the Wall Street Journal reports.

The Biden Administration earlier this month said that adults in the US who had received either the Pfizer-BioNTech or Moderna SARS-CoV-2 vaccines could soon be eligible for a booster vaccine about eight months after their initial vaccinations. The announcement was criticized by the World Health Organization, which said that the focus should be on getting more of the world their initial doses. However, the Washington Post reports that Hans Kluge, the WHO Europe head, has said that boosters might be valuable for at-risk populations.

The CDC's Advisory Committee on Immunization Practices (ACIP) similarly says that boosters should be prioritized to prevent severe disease among people at high risk of becoming ill with COVID-19, such as healthcare workers, nursing home residents, and others who were prioritized to receive the initial shots first, the Journal reports. It adds that ACIP further stressed that immunizing the unvaccinated should be the main concern.